Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Cutaneous Mastocytosis

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Cutaneous Mastocytosis in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ritter, M1
El-Nour, H1
Hedblad, MA1
Butterfield, JH1
Beck, O1
Stephanson, N1
Holst, M1
Giscombe, R1
Azmitia, EC1
Nordlind, K1

Trials

1 trial available for 8-hydroxy-2-(di-n-propylamino)tetralin and Cutaneous Mastocytosis

ArticleYear
Serotonin and its 5-HT1 receptor in human mastocytosis.
    Immunopharmacology and immunotoxicology, 2012, Volume: 34, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Cell Line; Female; Gene Expression Regulation, Neopla

2012